Adicet Bio Inc.
ACET | NASDAQ
$8.93
-$0.25 (-2.72%)
At close: Sep 21, 2026, 4:00 PM ET
$8.88
-$0.05 (-0.56%)
Pre-market:
Sep 22, 2026, 7:40 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | 24.99M | 9.73M | 17.9M |
Cost of Revenue | 6.38M | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -6.38M | n/a | n/a | 24.99M | 9.73M | 17.9M |
Operating Income | -122.11M | -127.62M | -152.04M | -72.55M | -61.43M | -39.19M |
Interest Income | 5.78M | 10.71M | 9.98M | 3.76M | 91K | 785K |
Pretax Income | -116.8M | -117.12M | -142.66M | -69.79M | -62.12M | -39.49M |
Net Income | -116.8M | -117.12M | -142.66M | -69.79M | -62M | -36.68M |
Selling & General & Admin | 22.99M | 28.29M | 26.53M | 26.3M | 22.22M | 22.76M |
Research & Development | 99.13M | 99.32M | 106.04M | 71.25M | 48.94M | 34.33M |
Other Expenses | -6.38M | n/a | 19.46M | n/a | n/a | n/a |
Operating Expenses | 115.73M | 127.62M | 152.04M | 97.54M | 71.16M | 57.09M |
Interest Expense | 36K | 4K | 25K | 80K | 176K | 134K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 122.11M | 127.62M | 152.04M | 97.54M | 71.16M | 57.09M |
Income Tax Expense | n/a | n/a | n/a | n/a | -125K | -2.82M |
Shares Outstanding (Basic) | 6.89M | 5.49M | 2.69M | 2.57M | 1.93M | 457.5K |
Shares Outstanding (Diluted) | 6.89M | 5.49M | 2.69M | 2.57M | 1.93M | 457.5K |
EPS (Basic) | -16.95 | -21.28 | -52.96 | -27.20 | -32 | -80.16 |
EPS (Diluted) | -16.95 | -21.28 | -52.96 | -27.20 | -32 | -80.16 |
EBITDA | -110.39M | -110.65M | -136.54M | -64.7M | -60.41M | -37.41M |
EBIT | -116.77M | -117.12M | -142.63M | -69.71M | -61.95M | -39.36M |
Depreciation & Amortization | 6.38M | 6.47M | 6.1M | 5.01M | 1.54M | 1.95M |
Add to Watchlist
Select watchlists to add or remove ACET